Park Edge Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Buy
5,887
+608
+12% +$130K 0.26% 74
2026
Q1
$1.17M Buy
5,279
+12
+0.2% +$2.94K 0.27% 64
2025
Q4
$1.34M Buy
5,267
+51
+1% +$12.8K 0.3% 68
2025
Q3
$1.29M Hold
5,216
0.3% 66
2025
Q2
$1.25M Buy
5,216
+507
+11% +$118K 0.32% 60
2025
Q1
$1.07M Buy
4,709
+47
+1% +$10.3K 0.3% 60
2024
Q4
$958K Buy
4,662
+51
+1% +$11.2K 0.28% 64
2024
Q3
$1.12M Hold
4,611
0.32% 66
2024
Q2
$1.01M Buy
4,611
+202
+5% +$43.9K 0.31% 55
2024
Q1
$991K Hold
4,409
0.28% 55
2023
Q4
$969K Buy
4,409
+51
+1% +$10.8K 0.34% 41
2023
Q3
$956K Buy
+4,358
New +$986K 0.34% 35

Other funds holding STE

Park Edge Advisors's STE Position: Q2 2026 in Review

Park Edge Advisors increased its Steris (STE) stake by 12% in Q2 2026, buying an estimated $130K and bringing the position to 5,887 shares worth $1.24M. The position accounts for 0.26% of the portfolio, ranked #74.

Park Edge Advisors first reported a position in STE in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.34M in Q4 2025. 91 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Park Edge Advisors held 5,887 shares of Steris worth $1.24M as of Q2 2026.
  • Park Edge Advisors bought 608 Steris shares in Q2 2026, an estimated $130K.
  • Steris made up 0.26% of Park Edge Advisors's portfolio in Q2 2026, its #74 holding.
  • Park Edge Advisors first reported a position in Steris in Q3 2023 and has held it in 12 quarters since.
  • Park Edge Advisors's Steris position peaked at $1.34M in Q4 2025.
  • 91 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Park Edge Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.